SAN DIEGO, Sept. 22, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento” or “Company”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the consummation on September 21, 2023, of the previously announced sale to Scilex Holding Company (Nasdaq:…Read More
Sorrento Therapeutics Inc Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
